Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Romiplostim appears to be safe in MDS patients with thrombocytopenia

Jan. 27, 2010

EMEA initiates review of Amsterdam MolecularTherapeutics' MAA for Glybera in LPLD

Jan. 27, 2010

Transition Therapeutics reports results from phase II trial of TT-223 in type 2 diabetes

Jan. 26, 2010

CHMP recommends suspension of marketing authorization for sibutramine

Jan. 26, 2010

Osiris completes enrollment in phase II trial of Prochymal in type 1 diabetes

Jan. 26, 2010

Affymax completes treatment in phase III trial of Hematide for anemia in CRF

Jan. 26, 2010

FDA sets PDUFA date for Genzyme's BLA for Lumizyme

Jan. 26, 2010

Pharming presents update on European CHMP's review of MAA for Rhucin in HAE

Jan. 25, 2010

GAA gene variants responsive to Pompe's disease candidate AT-2220 identified

Jan. 25, 2010

Gentamicin induces readthrough of termination codons in Stuve-Wiedermann syndrome

Jan. 25, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...